Guangxi Wuzhou Zhongheng Group Co Ltd (600252) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangxi Wuzhou Zhongheng Group Co Ltd (600252) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-76.63 Million ≈ $-11.21 Million USD) by net assets (CN¥7.26 Billion ≈ $1.06 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangxi Wuzhou Zhongheng Group Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Guangxi Wuzhou Zhongheng Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Guangxi Wuzhou Zhongheng Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangxi Wuzhou Zhongheng Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dezhan HealthCare Co Ltd
SHE:000813
|
0.000x |
|
Ingenia Communities Group
AU:INA
|
0.045x |
|
Three Squirrels
SHE:300783
|
0.001x |
|
Pharming Group NV
NASDAQ:PHAR
|
0.133x |
|
Waypoint REIT
AU:WPR
|
0.029x |
|
SILEX Systems Ltd
AU:SLX
|
0.027x |
|
Nanobiotix
NASDAQ:NBTX
|
0.253x |
|
Meren Energy
ST:MER
|
0.166x |
Annual Cash Flow Conversion Efficiency for Guangxi Wuzhou Zhongheng Group Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Guangxi Wuzhou Zhongheng Group Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see Guangxi Wuzhou Zhongheng Group Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.51 Billion ≈ $1.10 Billion |
CN¥477.43 Million ≈ $69.86 Million |
0.064x | +8.62% |
| 2023-12-31 | CN¥8.28 Billion ≈ $1.21 Billion |
CN¥484.10 Million ≈ $70.84 Million |
0.058x | +385.05% |
| 2022-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
CN¥-170.09 Million ≈ $-24.89 Million |
-0.021x | -132.36% |
| 2021-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
CN¥-76.74 Million ≈ $-11.23 Million |
-0.009x | -111.07% |
| 2020-12-31 | CN¥8.23 Billion ≈ $1.20 Billion |
CN¥656.62 Million ≈ $96.08 Million |
0.080x | -21.97% |
| 2019-12-31 | CN¥6.40 Billion ≈ $936.15 Million |
CN¥654.31 Million ≈ $95.75 Million |
0.102x | -28.93% |
| 2018-12-31 | CN¥5.93 Billion ≈ $867.77 Million |
CN¥853.40 Million ≈ $124.88 Million |
0.144x | -9.83% |
| 2017-12-31 | CN¥5.60 Billion ≈ $818.98 Million |
CN¥893.21 Million ≈ $130.71 Million |
0.160x | -43.17% |
| 2016-12-31 | CN¥5.33 Billion ≈ $779.28 Million |
CN¥1.50 Billion ≈ $218.86 Million |
0.281x | +377.32% |
| 2015-12-31 | CN¥4.95 Billion ≈ $725.03 Million |
CN¥291.53 Million ≈ $42.66 Million |
0.059x | -38.91% |
| 2014-12-31 | CN¥5.92 Billion ≈ $865.96 Million |
CN¥569.95 Million ≈ $83.40 Million |
0.096x | -62.41% |
| 2013-12-31 | CN¥3.69 Billion ≈ $539.83 Million |
CN¥945.10 Million ≈ $138.30 Million |
0.256x | -12.24% |
| 2012-12-31 | CN¥3.11 Billion ≈ $454.39 Million |
CN¥906.43 Million ≈ $132.64 Million |
0.292x | +255.33% |
| 2011-12-31 | CN¥2.00 Billion ≈ $292.73 Million |
CN¥-375.93 Million ≈ $-55.01 Million |
-0.188x | -231.00% |
| 2010-12-31 | CN¥1.34 Billion ≈ $195.58 Million |
CN¥191.73 Million ≈ $28.06 Million |
0.143x | +394.70% |
| 2009-12-31 | CN¥576.93 Million ≈ $84.42 Million |
CN¥-28.08 Million ≈ $-4.11 Million |
-0.049x | -137.00% |
| 2008-12-31 | CN¥451.95 Million ≈ $66.13 Million |
CN¥59.47 Million ≈ $8.70 Million |
0.132x | +33.92% |
| 2007-12-31 | CN¥414.81 Million ≈ $60.70 Million |
CN¥40.75 Million ≈ $5.96 Million |
0.098x | -82.41% |
| 2006-12-31 | CN¥356.94 Million ≈ $52.23 Million |
CN¥199.41 Million ≈ $29.18 Million |
0.559x | +283.23% |
| 2005-12-31 | CN¥385.08 Million ≈ $56.35 Million |
CN¥56.14 Million ≈ $8.21 Million |
0.146x | -51.80% |
| 2004-12-31 | CN¥476.29 Million ≈ $69.70 Million |
CN¥144.06 Million ≈ $21.08 Million |
0.302x | +207.96% |
| 2003-12-31 | CN¥438.88 Million ≈ $64.22 Million |
CN¥-122.95 Million ≈ $-17.99 Million |
-0.280x | -77.66% |
| 2002-12-31 | CN¥428.29 Million ≈ $62.67 Million |
CN¥-67.54 Million ≈ $-9.88 Million |
-0.158x | -436.43% |
| 2001-12-31 | CN¥399.28 Million ≈ $58.43 Million |
CN¥-11.74 Million ≈ $-1.72 Million |
-0.029x | +36.69% |
| 2000-12-31 | CN¥375.55 Million ≈ $54.95 Million |
CN¥-17.44 Million ≈ $-2.55 Million |
-0.046x | -113.21% |
| 1999-12-31 | CN¥148.77 Million ≈ $21.77 Million |
CN¥52.29 Million ≈ $7.65 Million |
0.351x | -- |
About Guangxi Wuzhou Zhongheng Group Co Ltd
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicines; and xueshuantong for shooting, zhonghua dieda pills, angong niuhuang pills, shedan chuanbei liquid, fuyanjing capsules, jieshitong tablets, yanjianning tablets, sodium fluorescein injection under the Zhon… Read more